Wall J R, Hayes M, Scalise D, Stolarski C, Nebes V, Kiljanski J, Salvi M, Sato M
Allegheny-Singer Research Institute, Pittsburgh, Pennsylvania 15212, USA.
J Clin Endocrinol Metab. 1995 Apr;80(4):1226-32. doi: 10.1210/jcem.80.4.7714092.
Although sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting are widely used to detect serum antibodies in patients with autoimmune disorders, this procedure unfolds and denatures proteins and may alter antibody-binding sites. We have used a gentle protocol for the preparation and purification of a 64-kilodalton (kDa) eye muscle (EM) membrane antigen associated with thyroid-associated ophthalmopathy (TAO) for use as antigen in immunoblotting. Pig EM membrane proteins were prepared from crude homogenates by high speed centrifugation and solubilized by hand homogenization. These native membrane proteins (NMprot) were then electrophoresed on an 8.5% polyacrylamide gel in the absence of SDS, reducing agents, or urea, and proteins from individual bands were eluted, applied to standard SDS-PAGE, and immunoblotted with selected TAO patient sera. A prominent 64-kDa protein, present in most of the bands, was recognized by autoantibodies in sera from 35% of the patients with TAO and 47% of those with Graves' hyperthyroidism without evident ophthalmopathy, but in only 4% of normal subjects. To further purify the 64-kDa protein and increase the sensitivity of immunoblotting, NMprot were separated by isoelectric focusing (IEF) in the absence of SDS, reducing agent, and urea. The 64-kDa protein appeared mainly in IEF fraction 7 and had an isoelectric point of 6.1-6.2. Similar results were found for a human EM protein of 64 kDa. Sera from groups of patients and normal subjects were tested in immunoblotting against a pig EM 64-kDa protein prepared from NMprot and purified in IEF. Tests were positive in 67% of patients with TAO, in 37.5% of those with Graves' hyperthyroidism without eye disease, in 11% of patients with Hashimoto's thyroiditis without eye disease, and in 9% of normal subjects. The 64-kDa protein was not found in other skeletal muscle. The demonstration that a native 64-kDa protein that is specifically targeted by autoantibodies in the serum of patients with TAO is expressed in EM, but not other skeletal muscle, greatly enhances its possible significance in the pathogenesis of this eye disorder.
尽管十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)和蛋白质印迹法被广泛用于检测自身免疫性疾病患者的血清抗体,但该方法会使蛋白质展开并变性,可能改变抗体结合位点。我们采用了一种温和的方案来制备和纯化与甲状腺相关眼病(TAO)相关的64千道尔顿(kDa)眼肌(EM)膜抗原,用作免疫印迹中的抗原。猪EM膜蛋白由粗匀浆通过高速离心制备,并通过手工匀浆溶解。然后将这些天然膜蛋白(NMprot)在不含SDS、还原剂或尿素的情况下在8.5%聚丙烯酰胺凝胶上进行电泳,从各个条带中洗脱蛋白质,应用于标准SDS-PAGE,并与选定的TAO患者血清进行免疫印迹。在大多数条带中存在的一种突出的64-kDa蛋白,在35%的TAO患者和47%无明显眼病的格雷夫斯甲状腺功能亢进患者的血清中被自身抗体识别,但在仅4%的正常受试者中被识别。为了进一步纯化64-kDa蛋白并提高免疫印迹的灵敏度,在不含SDS、还原剂和尿素的情况下通过等电聚焦(IEF)分离NMprot。64-kDa蛋白主要出现在IEF组分7中,等电点为6.1-6.2。对于64 kDa的人EM蛋白也发现了类似结果。对由NMprot制备并在IEF中纯化的猪EM 64-kDa蛋白进行免疫印迹,检测患者组和正常受试者组的血清。TAO患者中有67%检测呈阳性,无眼部疾病的格雷夫斯甲状腺功能亢进患者中有37.5%呈阳性,无眼部疾病的桥本甲状腺炎患者中有11%呈阳性,正常受试者中有9%呈阳性。在其他骨骼肌中未发现64-kDa蛋白。证明TAO患者血清中自身抗体特异性靶向的天然64-kDa蛋白在EM中表达,但不在其他骨骼肌中表达,极大地增强了其在这种眼部疾病发病机制中的可能意义。